KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Depreciation & Amortization (CF): 2009-2025

Historic Depreciation & Amortization (CF) for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $85.2 million.

  • Charles River Laboratories International's Depreciation & Amortization (CF) fell 3.44% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $427.1 million, marking a year-over-year increase of 25.57%. This contributed to the annual value of $361.7 million for FY2024, which is 15.16% up from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Depreciation & Amortization (CF) is $85.2 million, which was down 28.74% from $119.5 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Depreciation & Amortization (CF) registered a high of $120.4 million during Q1 2025, and its lowest value of $61.5 million during Q1 2021.
  • Over the past 3 years, Charles River Laboratories International's median Depreciation & Amortization (CF) value was $85.4 million (recorded in 2024), while the average stood at $91.0 million.
  • Data for Charles River Laboratories International's Depreciation & Amortization (CF) shows a peak YoY increase of 41.01% (in 2025) and a maximum YoY decrease of 3.44% (in 2025) over the last 5 years.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Depreciation & Amortization (CF) stood at $67.2 million in 2021, then grew by 15.32% to $77.5 million in 2022, then rose by 3.83% to $80.5 million in 2023, then increased by 26.82% to $102.1 million in 2024, then decreased by 3.44% to $85.2 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $85.2 million for Q3 2025, versus $119.5 million for Q2 2025 and $120.4 million for Q1 2025.